Ladies and gentlemen, I am pleased to report that BTC Health Limited (ASX:BTC) has achieved a number of milestones over the past 12 months, including a greater penetration of our products within hospitals.
BTC Health Limited (ASX:BTC) Shareholder Update - September 2021 - ABN Newswire (@ABN_Newswire) abnnewswire.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from abnnewswire.net Daily Mail and Mail on Sunday newspapers.
The primary objective for BTC Speciality Health is to increase market share through organic growth. New products will continue to be sourced by BioImpact and will enable BTC Speciality Health to expand its product range within pain management and critical care.
BTC Health Limited (ASX:BTC) Acquires Exclusive Distribution Rights for Bronchitol(R) and Aridol(R) from Pharmaxis
Acquires Exclusive Distribution Rights for Bronchitol(R) and Aridol(R) from PharmaxisMelbourne, July 6, 2021 AEST (ABN Newswire) - BTC Health Limited (
ASX:BTC) is pleased to announce its investee company, BioImpact Pty Ltd, has acquired exclusive distribution rights for specialty respiratory brands Bronchitol(R) and Aridol(R) from Pharmaxis (
ASX:PXS) in Australia, New Zealand, Singapore, Malaysia, Hong Kong and South Korea (Bronchitol(R) only).
The exclusive distribution agreement is effective 1 July 2021, with an initial term of 10 years and automatic renewals for subsequent 3-year terms. Pharmaxis will continue to manufacture and supply Bronchitol(R) and Aridol(R) to BTC health from its TGA approved facility in Sydney. As financial consideration for the distribution rights, BioImpact Pty Ltd will make a once-off payment of $2m to Pharmaxis within 10 bus
BTC Health Limited (ASX:BTC) $2 5m Capital Raise to Acquire the Distribution Rights to Bronchitol(R) and Aridol(R) abnnewswire.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from abnnewswire.net Daily Mail and Mail on Sunday newspapers.